Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Postmenopausal Hyperandrogenism: Evaluation and Treatment Strategies.

Literature DB >> 33518189

Postmenopausal Hyperandrogenism: Evaluation and Treatment Strategies.

Abstract

Evidence of clinical and/or biochemical androgen excess poses a unique differential in postmenopausal women. Some signs and symptoms of postmenopausal hyperandrogenism can be normal and attributed to the natural aging process. However, the causes of androgen excess in this group include both nontumorous and tumorous causes. Treatment of androgen excess may improve both quality of life and long-term metabolic outcomes.

Entities: Chemical

Keywords: Adrenal tumor(s); Hyperandrogenism; Hyperthecosis; Ovarian tumor(s); Postmenopausal; Virilization

Mesh：

Substances：
Testosterone

Year: 2021 PMID： 33518189 PMCID： PMC9004339 DOI： 10.1016/j.ecl.2020.12.002

Source DB: PubMed Journal: Endocrinol Metab Clin North Am ISSN： 0889-8529 Impact factor: 4.741

56 in total

Review 1. Insulin-sensitizing agents in the treatment of polycystic ovary syndrome: an update.

Authors: Niki Katsiki; Apostolos I Hatzitolios
Journal: Curr Opin Obstet Gynecol Date: 2010-12 Impact factor: 1.927

2. Menstrual irregularity in women with acromegaly.

Authors: G A Kaltsas; J J Mukherjee; P J Jenkins; M A Satta; N Islam; J P Monson; G M Besser; A B Grossman
Journal: J Clin Endocrinol Metab Date: 1999-08 Impact factor: 5.958

3. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.

Authors: Marios C Markopoulos; Demetrios Rizos; George Valsamakis; Efthimios Deligeoroglou; Odysseas Grigoriou; George P Chrousos; George Creatsas; George Mastorakos
Journal: J Clin Endocrinol Metab Date: 2010-12-22 Impact factor: 5.958

4. Androgen levels in adult females: changes with age, menopause, and oophorectomy.

Authors: S L Davison; R Bell; S Donath; J G Montalto; S R Davis
Journal: J Clin Endocrinol Metab Date: 2005-04-12 Impact factor: 5.958

5. Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement.

Authors: William Rosner; Richard J Auchus; Ricardo Azziz; Patrick M Sluss; Hershel Raff
Journal: J Clin Endocrinol Metab Date: 2006-11-07 Impact factor: 5.958

6. Impact of clinical, hormonal, radiological, and immunohistochemical studies on the diagnosis of postmenopausal hyperandrogenism.

Authors: Julie Sarfati; Anne Bachelot; Christiane Coussieu; Géri Meduri; Philippe Touraine
Journal: Eur J Endocrinol Date: 2011-09-06 Impact factor: 6.664

7. Androgen-secreting adrenal tumors.

Authors: Fernando Cordera; Clive Grant; Jon van Heerden; Geoffrey Thompson; William Young
Journal: Surgery Date: 2003-12 Impact factor: 3.982

8. Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours.

Authors: M M Pascale; M Pugeat; M Roberts; H Rousset; H Déchaud; N Dutrieux-Berger; J Tourniaire
Journal: Clin Endocrinol (Oxf) Date: 1994-11 Impact factor: 3.478

Review 9. Hyperandrogenism after menopause.

Authors: Marios C Markopoulos; Evanthia Kassi; Krystallenia I Alexandraki; George Mastorakos; Gregory Kaltsas
Journal: Eur J Endocrinol Date: 2014-09-15 Impact factor: 6.664